Help about sample size calculation
For my study, the primary endpoint is to determine the proportion of patients who experience a beneficial effect after receiving the treatment. We have established a null hypothesis proportion (퐻0) of 0.5, indicating our expectation that approximately 50% of the patients will exhibit a beneficial response to the treatment post-intervention. This figure serves as a clinically relevant cut-off point...